AU2026202464A1 - Pharmaceutical Drug Containing Heterocyclidene Acetamide Derivative - Google Patents
Pharmaceutical Drug Containing Heterocyclidene Acetamide DerivativeInfo
- Publication number
- AU2026202464A1 AU2026202464A1 AU2026202464A AU2026202464A AU2026202464A1 AU 2026202464 A1 AU2026202464 A1 AU 2026202464A1 AU 2026202464 A AU2026202464 A AU 2026202464A AU 2026202464 A AU2026202464 A AU 2026202464A AU 2026202464 A1 AU2026202464 A1 AU 2026202464A1
- Authority
- AU
- Australia
- Prior art keywords
- dry eye
- item
- composition
- eye
- zone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2026202464A AU2026202464A1 (en) | 2019-10-04 | 2026-03-31 | Pharmaceutical Drug Containing Heterocyclidene Acetamide Derivative |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019184053 | 2019-10-04 | ||
| JP2019-184053 | 2019-10-04 | ||
| PCT/JP2020/037548 WO2021066144A1 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| AU2020361093A AU2020361093B2 (en) | 2019-10-04 | 2020-10-02 | Pharmaceutical drug containing heterocyclidene acetamide derivative |
| AU2026202464A AU2026202464A1 (en) | 2019-10-04 | 2026-03-31 | Pharmaceutical Drug Containing Heterocyclidene Acetamide Derivative |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020361093A Division AU2020361093B2 (en) | 2019-10-04 | 2020-10-02 | Pharmaceutical drug containing heterocyclidene acetamide derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2026202464A1 true AU2026202464A1 (en) | 2026-04-16 |
Family
ID=75338162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2026202464A Pending AU2026202464A1 (en) | 2019-10-04 | 2026-03-31 | Pharmaceutical Drug Containing Heterocyclidene Acetamide Derivative |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12533337B2 (https=) |
| EP (2) | EP4545095A3 (https=) |
| JP (4) | JP7025094B2 (https=) |
| KR (1) | KR20220078604A (https=) |
| CN (1) | CN114585357A (https=) |
| AU (1) | AU2026202464A1 (https=) |
| BR (1) | BR112022005992A2 (https=) |
| CA (1) | CA3156484A1 (https=) |
| DK (1) | DK4043014T3 (https=) |
| ES (1) | ES3031607T3 (https=) |
| HU (1) | HUE072085T2 (https=) |
| MX (2) | MX2022004027A (https=) |
| MY (1) | MY207759A (https=) |
| PH (1) | PH12022550805A1 (https=) |
| PL (1) | PL4043014T3 (https=) |
| PT (1) | PT4043014T (https=) |
| WO (1) | WO2021066144A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3156484A1 (en) | 2019-10-04 | 2021-04-08 | Senju Pharmaceutical Co., Ltd. | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE |
| CN117120048A (zh) | 2021-03-30 | 2023-11-24 | 千寿制药株式会社 | 含杂环亚基乙酰胺衍生物的悬浮液 |
| KR20250065723A (ko) | 2022-09-29 | 2025-05-13 | 센주 세이야꾸 가부시키가이샤 | 멸균 처리한 헤테로시클리덴아세트아미드 유도체 함유 현탁액 |
| JP7589394B2 (ja) * | 2022-09-29 | 2024-11-25 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体を含む配合剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5621566A (en) | 1979-08-01 | 1981-02-28 | Alpha- Shokuhin Kk | Preparation of bifun from homegrown rice and apparatus used for it |
| CN101228131B (zh) * | 2005-07-22 | 2013-01-09 | 持田制药株式会社 | 新的杂环亚基乙酰胺衍生物 |
| JP4754566B2 (ja) | 2005-07-22 | 2011-08-24 | 持田製薬株式会社 | 新規なヘテロシクリデンアセトアミド誘導体 |
| RU2451014C2 (ru) | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| TW200927192A (en) | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| EP2377850A1 (en) | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| WO2012045729A1 (en) * | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
| GB201215857D0 (en) * | 2012-09-05 | 2012-10-24 | Sylentis Sau | siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| JP7373909B2 (ja) | 2018-04-06 | 2023-11-06 | 株式会社シマノ | 変速制御装置および変速システム |
| CA3156484A1 (en) | 2019-10-04 | 2021-04-08 | Senju Pharmaceutical Co., Ltd. | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE |
-
2020
- 2020-10-02 CA CA3156484A patent/CA3156484A1/en active Pending
- 2020-10-02 PH PH1/2022/550805A patent/PH12022550805A1/en unknown
- 2020-10-02 CN CN202080069192.5A patent/CN114585357A/zh active Pending
- 2020-10-02 MY MYPI2022001736A patent/MY207759A/en unknown
- 2020-10-02 JP JP2021541679A patent/JP7025094B2/ja active Active
- 2020-10-02 KR KR1020227012080A patent/KR20220078604A/ko active Pending
- 2020-10-02 PL PL20872061.5T patent/PL4043014T3/pl unknown
- 2020-10-02 PT PT208720615T patent/PT4043014T/pt unknown
- 2020-10-02 WO PCT/JP2020/037548 patent/WO2021066144A1/ja not_active Ceased
- 2020-10-02 EP EP25164201.3A patent/EP4545095A3/en active Pending
- 2020-10-02 DK DK20872061.5T patent/DK4043014T3/da active
- 2020-10-02 EP EP20872061.5A patent/EP4043014B1/en active Active
- 2020-10-02 MX MX2022004027A patent/MX2022004027A/es unknown
- 2020-10-02 HU HUE20872061A patent/HUE072085T2/hu unknown
- 2020-10-02 BR BR112022005992A patent/BR112022005992A2/pt unknown
- 2020-10-02 ES ES20872061T patent/ES3031607T3/es active Active
- 2020-10-02 US US17/766,090 patent/US12533337B2/en active Active
-
2022
- 2022-02-07 JP JP2022017196A patent/JP7248836B2/ja active Active
- 2022-04-01 MX MX2025005474A patent/MX2025005474A/es unknown
- 2022-10-26 JP JP2022171542A patent/JP7801201B2/ja active Active
-
2025
- 2025-01-03 US US19/009,260 patent/US12502375B2/en active Active
-
2026
- 2026-01-05 JP JP2026000075A patent/JP2026042857A/ja active Pending
- 2026-03-31 AU AU2026202464A patent/AU2026202464A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022065024A (ja) | 2022-04-26 |
| EP4043014A4 (en) | 2023-10-11 |
| MY207759A (en) | 2025-03-17 |
| WO2021066144A1 (ja) | 2021-04-08 |
| CA3156484A1 (en) | 2021-04-08 |
| EP4545095A2 (en) | 2025-04-30 |
| US12502375B2 (en) | 2025-12-23 |
| PH12022550805A1 (en) | 2023-10-02 |
| JPWO2021066144A1 (ja) | 2021-12-02 |
| DK4043014T3 (da) | 2025-06-23 |
| HUE072085T2 (hu) | 2025-10-28 |
| JP7248836B2 (ja) | 2023-03-29 |
| MX2025005474A (es) | 2025-06-02 |
| US20220370404A1 (en) | 2022-11-24 |
| EP4043014B1 (en) | 2025-03-19 |
| US20250134854A1 (en) | 2025-05-01 |
| AU2020361093A1 (en) | 2022-05-19 |
| MX2022004027A (es) | 2022-07-19 |
| JP2023011735A (ja) | 2023-01-24 |
| JP7801201B2 (ja) | 2026-01-16 |
| PT4043014T (pt) | 2025-06-09 |
| KR20220078604A (ko) | 2022-06-10 |
| PL4043014T3 (pl) | 2025-08-11 |
| CN114585357A (zh) | 2022-06-03 |
| US12533337B2 (en) | 2026-01-27 |
| ES3031607T3 (en) | 2025-07-09 |
| EP4545095A3 (en) | 2025-07-02 |
| BR112022005992A2 (pt) | 2022-06-21 |
| JP2026042857A (ja) | 2026-03-11 |
| EP4043014A1 (en) | 2022-08-17 |
| JP7025094B2 (ja) | 2022-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12502375B2 (en) | Pharmaceutical drug containing heterocyclidene acetamide derivative | |
| JP6861764B2 (ja) | 軸索再生および神経機能を促進するための方法および組成物 | |
| AU2016268872B2 (en) | Use of cannabinoids in the treatment of ocular inflammation and/or pain | |
| EP4275705B1 (en) | Pancreatitis treatment | |
| JP6574769B2 (ja) | 二環式化合物ならびに自閉症スペクトラム障害および神経発達障害の治療におけるそれらの使用方法 | |
| CN119656170A (zh) | 使用尼达尼布来治疗具有异常新生血管形成的眼病的组合物和方法 | |
| JP2021508331A (ja) | 眼投与のためのｗ／ｏ／ｗマイクロエマルジョン | |
| KR20160070077A (ko) | 안구내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조 방법 | |
| KR102902220B1 (ko) | 4-페닐부티르산을 함유하는 노시의 치료 또는 예방제 | |
| EP3302464A1 (en) | Use of cannabinoids in the treatment of ocular inflammation and/or pain | |
| WO2013049621A1 (en) | Ophthalmic compositions comprising ppar-alpha agonists and methods of production and use thereof | |
| US20240423937A1 (en) | Methods of treating pain and uses thereof | |
| AU2020361093B2 (en) | Pharmaceutical drug containing heterocyclidene acetamide derivative | |
| US20240156765A1 (en) | Methods of neuroprotection and uses thereof | |
| WO2018079149A1 (ja) | 白内障の予防剤、治療剤、およびこれらを製造するためのｈａｔ阻害剤の使用 | |
| WO2016068278A1 (ja) | 水晶体硬化抑制剤 | |
| BR122025000958A2 (pt) | Composições contendo derivado de heterociclideno acetamida e seus usos | |
| US20260048096A1 (en) | Methods and compositions for preserving the retinal outer nuclear layer (onl), photoreceptors, and retinal thickness | |
| Ribeiro et al. | Effects of meloxicam administered by different routes to control experimental uveitis in dogs | |
| WO2016199871A1 (ja) | 神経麻痺性角膜症の治療薬 | |
| HK40000009A (zh) | 使用尼达尼布来治疗具有异常新生血管形成的眼病的组合物和方法 | |
| BR122024009541A2 (pt) | Composição compreendendo nintedanib para tratar doenças oculares com neovascularização anormal |